'Exciting' Lung Cancer Drug Approved for CDF - Medscape

'Exciting' Lung Cancer Drug Approved for CDF  Medscape

Approval for CDF inclusion of 'exciting' immunotherapy drug durvalumab for some lung cancer patients was among this week's announcements by NICE.



Comments

Popular posts from this blog

Oncology: The disease, dynamics & challenges of market research

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Lung Cancer Among People Who Never Smoked